-
Micellar Spectrofluorimetry of Alfuzosin and Vardenafil
2026-08-26
The reference study introduced a direct micellar spectrofluorimetric method for simultaneous quantitation of alfuzosin hydrochloride and vardenafil hydrochloride. By using sodium dodecyl sulfate to enhance native fluorescence, the method supported analysis of raw materials, tablets, plasma, and urine with nanogram-level sensitivity.
-
Angiotensin II Workflows for Cardiovascular Research
2026-08-26
Build reproducible Angiotensin II cell and animal workflows for hypertension mechanism studies, metabolic stress assays, vascular remodeling, and abdominal aortic aneurysm models. The approach combines controlled peptide handling with the miR-1268a–CD36 findings reported in cardiomyocyte research to improve assay selection and interpretation.
-
ABT-888 (Veliparib) for DNA Repair Studies
2026-08-25
ABT-888 (Veliparib) provides a practical way to suppress PARP1/2 activity while testing chemotherapy, radiation, and DNA damage response dependencies. This guide connects concentration planning, combination assays, MSI and colorectal cancer models, and the reference study’s important negative PARP result.
-
Exercise, Muscle EVs, and Amyloid Clearance in AD
2026-08-25
A 2026 Nature Aging study identifies skeletal muscle-derived extracellular vesicles as a mechanistic link between swimming exercise and improved cognition in Alzheimer’s disease mice. The work connects EV uptake by microglia to disease-associated polarization, amyloid-beta plaque clearance, and a miR-378a-3p–p110α lipid-metabolism pathway, suggesting an exercise-mimicking strategy rather than a simple behavioral association.
-
Persister Lipidomics and Ferroptosis Sensitivity
2026-08-24
Reznik and colleagues show that drug-tolerant persister cancer cells acquire a reversible lipidomic state enriched in ferroptosis-driving diPUFA phospholipids and polyunsaturated fatty acids. Cross-model validation and mitochondrial elimination experiments support a mitochondria-dependent metabolic vulnerability relevant to minimal residual disease research.
-
α-Amanitin A4548: Reliable Transcription Assays
2026-08-24
Learn how α-Amanitin (SKU A4548) can clarify transcription-dependent changes in viability, proliferation, and cytotoxicity assays. This scenario-based guide covers mechanism, assay compatibility, protocol parameters, data interpretation, and practical product-selection criteria supported by product information and published evidence.
-
Angiotensin 1/2 (5-7): Assay Design Guide
2026-08-23
Explore Angiotensin 1/2 (5-7), the H2N-Ile-His-Pro-OH peptide, through a fragment-first framework for renin-angiotensin system research. This guide connects peptide identity, assay controls, cardiovascular interpretation, and emerging SARS-CoV-2 spike-binding evidence.
-
VX-702: A Practical p38α MAPK Inhibitor Workflow
2026-08-22
VX-702 combines selective p38α MAPK inhibition with a practical workflow for cytokine, platelet, arthritis, and cardiac injury studies. This guide connects target-engagement assays to translational models while highlighting solvent control, phospho-signaling interpretation, and troubleshooting strategies.
-
From SA-β-Gal Signal to Senolytic Strategy
2026-08-22
A translational framework for connecting SA-β-Gal detection with senolytic drug discovery, experimental controls, and evidence-based cellular aging research.
-
VX-702: From p38α Blockade to Translational Design
2026-08-21
A mechanistic and translational framework for using VX-702 to study p38α MAPK signaling, cytokine control, inflammatory disease models, platelet biology, and cardiac injury while keeping preclinical evidence in context.
-
Amikacin Disulfate: Designing Better Mechanism Assays
2026-08-20
Amikacin disulfate enables layered studies of ribosomal inhibition, protein interactions, and antibiotic resistance. This guide translates recent lysozyme-binding evidence into practical assay-design decisions without confusing protein complexation with the drug’s primary bacterial target.
-
Ruthenium Red in Mechanostress Calcium Assays
2026-08-20
Ruthenium Red helps separate calcium-dependent signaling from cytoskeletal mechanics in compression-induced autophagy experiments. Its water compatibility and broad membrane activity also support mitochondrial calcium uptake inhibition, sarcoplasmic-reticulum studies, and neurogenic inflammation models when paired with rigorous controls.
-
Tobramycin: In Vitro Workflows and Troubleshooting
2026-08-19
Tobramycin provides a water-based route for studying 30S ribosome inhibition, Gram-negative susceptibility, and resistance-associated shifts in growth. This practical guide translates a classic comparative microtiter study into reproducible assay setup, optimization, and troubleshooting decisions.
-
Roscovitine Workflows for CDK and Cell-Cycle Studies
2026-08-19
Roscovitine, also called Seliciclib, provides a practical way to connect CDK biochemistry with reversible cell-cycle phenotypes and translational tumor models. This workflow emphasizes dose design, orthogonal readouts, washout experiments, and library-aware controls so researchers can distinguish useful pathway engagement from concentration-dependent off-target effects.
-
Dacomitinib Workflows for ErbB Signaling Research
2026-08-18
Build reproducible Dacomitinib assays that connect irreversible pan-HER blockade with receptor signaling, apoptosis, cell-cycle analysis, and resistance biology. The workflow also shows how to evaluate a carefully bounded, exploratory link between ErbB inhibition and the METTL17–mitochondrial ferroptosis axis.